One Step Further on the Global Stage | 3Srobotics Makes Its North American Debut at FABTECH US 2026
PR Newswire
Today at 6:44am UTC
Enterome Phase 1/2 data show OncoMimics™ EO4010-induced CD8 T-cell expansion was associated with longer survival in patients with colorectal...
GlobeNewswire
Today at 6:30am UTC
Sigma FP2 Mirrorless Camera Evolves the Compact, Hybrid, Full-Frame Formula, Announced; YouTube First Look Video and More Info at B&H
GlobeNewswire
Today at 6:30am UTC
Securitas AB Interim Report Q3 2026 | January-September
PR Newswire
Today at 6:29am UTC
2026 CSCCP-ASCCP Colposcopy Training Course--Wuhan Station Concludes, Promoting More Precise and Non-Invasive Management of Cervical Lesions
PR Newswire
Today at 6:03am UTC
Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with...
GlobeNewswire
Today at 6:00am UTC
Full-Life Technologies Reports Encouraging Preliminary Phase 1 Safety and PSA Decline for FL-020 in mCRPC at ESMO 2026
PR Newswire
Today at 6:00am UTC
Rakuten Medical Presents Long-Term Follow-up Results of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for R/M HNSCC at ESMO...
PR Newswire
Today at 6:00am UTC
Dott Publishes Q3 2026 Financial Report
PR Newswire
Today at 6:00am UTC
AIMIA TO REPORT THIRD QUARTER 2026 RESULTS ON NOVEMBER 6
PR Newswire
Today at 6:00am UTC
Saab Q3 results 2026: Positioned to capture growing demand
PR Newswire
Today at 5:53am UTC
Ipsos: Organic growth of 2.0% in Q3
GlobeNewswire
Today at 5:49am UTC
ASPR AI Launches Private Sales Agent Studio With Forward Deployed Engineers and 50+ Language Meeting Notetakers
PR Newswire
Today at 5:43am UTC
Volvo Group - the third quarter 2026
PR Newswire
Today at 5:42am UTC
Electrolux Group Interim report Q3 2026
PR Newswire
Today at 5:35am UTC
Volvo Cars Q3 2026: taking decisive action to navigate a very tough environment
PR Newswire
Today at 5:23am UTC
Umbrella Lab Announces Documentation and Traceability Update for BPC-157 Peptide
GlobeNewswire
Today at 5:18am UTC
Ascom completes share capital reduction following share buyback program
GlobeNewswire
Today at 5:00am UTC
Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South Korea
GlobeNewswire
Today at 5:00am UTC
Sodexo - Fiscal 2026 results: organic growth above guidance; Fiscal 2027 outlook confirmed
GlobeNewswire
Today at 5:00am UTC